Log In
Print this Print this


Also known as: NOxCureCF

  Manage Alerts
Collapse Summary General Information
Company Advanced Inhalation Therapies Ltd.
DescriptionInhaled nitric oxide (NO) formulated using the company's drug delivery system
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF)
Regulatory Designation U.S. - Orphan Drug (Treat cystic fibrosis (CF));
EU - Orphan Drug (Treat cystic fibrosis (CF))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today